Beijing: China’s State Council Information Office issued a white paper on Tuesday, titled “Fantinery-related material-China contributions,” which highlighted the country’s strict control over chemicals.
White paper has confirmed that China has shown great importance in controlling phenynel -related substances in recent years.
It notes that the country has used strict surveillance on fantasy -related drugs, strictly preventing the misuse of phenotheel -related substances, and is a severe attack against smuggling, manufacturing, and smuggling of fantasy -related materials and related advance chemicals.
It states that “they have presented significant results.
The document also emphasizes China’s commitment to enhance international cooperation on drug control through dialogue, joint investigations, and sharing of knowledge, while promoting equality and mutual trusting partnerships.
The White Paper states, “China has achieved significant achievements in resolving issues related to fantasy and their foremosts, including the United States, in deep cooperation with the concerned countries.”
According to the document, China has counted fantasy -related drugs in the list of drugs and exercises controlled in terms of their manufacture, sales, use and export. In addition to the White Paper, it has also been noted that China has actively worked to establish a digital tracking system for fantasy -related medicines.
Comprehensive use of new technologies and methods, such as radio frequency identification tags, internet offs, and artificial intelligence, manufacturing, sales, transportation, transport, use, use, import and export -related drug -related drug -related drug -related drug -related drugs, enables them to lose more.
The document states that China actively responds to new challenges associated with fantasy material.
CHINA has adopted integrated measures to prevent and overcome the misuse of material -related substances, such as increasing the list of controlled substances, stabilizing regular monitoring, inspection and solid control, and sorting of seizures.
For the vision of the Commonwealth Global Community, the White Paper says China strictly fulfills the responsibilities of controlling its international drugs, and is a comprehensive and balanced approach to controlling the principle of joint responsibility and drug control among all countries.
The document claims that “it supports mutual cooperation, joint contributions, and shared benefits between all countries, and opposes the identification of the finger and passing.”
White paper further emphasizes that China honors its drug control responsibilities, maintains the current international drug control system firmly, participating fully in making important decisions on international drug control, and contributes to global drug strategies.
